LIPELLA PHARMACEUTICALS INC (LIPO)

US53630L1008 - Common Stock

3.17  -0.01 (-0.31%)

After market: 3.29 +0.12 (+3.79%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023 2024 2025 2026
Revenue
YoY % growth
259.35K
-73.03%		184.16K
-28.99%		449.62K
144.15%		370.26K
-17.65%
-100.00%
EBITDA
YoY % growth
N/AN/A-4.744MN/AN/AN/A
EBIT
YoY % growth
-1.916M
-3,268.79%		-2.59M
-35.17%		-4.746M
-83.26%		-5.598M
-17.95%		-8.556M
-52.84%		-12.834M
-50.00%
Operating Margin
-738.70%-1,406.23%-1,055.55%-1,511.85%N/AN/A
EPS
YoY % growth
N/AN/AN/A-8.01-5.30
33.76%		-17.77
-235.00%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 24
EPS
Q2Q % growth		-2.48
Revenue
Q2Q % growth		N/A
EBITDA
Q2Q % growth		N/A
EBIT
Q2Q % growth		-1.896M
-159.89%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2024
Q2Q % growth		 -1.29 -0.98-0.31-31.74%
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q2 2024
Q2Q % growth		 136.43K
27.89%		%
Q1 2024
Q2Q % growth		 145.88K
23.57%		%
Q4 2023
Q2Q % growth		 120.84K
-19.98%		%
Q3 2023
Q2Q % growth		 104.05K
213.88%		%
Q4 2022
Q2Q % growth		 151.01K
483.50%		%
Q3 2022
Q2Q % growth		 33.15K
-85.80%		%
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% -700% 0% -1327.27%
RevenueN/A N/A 0% 28.72%